Palo Alto Investors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-39,300
Closed -$2.55M 38
2019
Q4
$2.55M Hold
39,300
0.14% 25
2019
Q3
$2.49M Sell
39,300
-136,600
-78% -$8.93M 0.17% 26
2019
Q2
$11.9M Hold
175,900
0.58% 23
2019
Q1
$11.4M Hold
175,900
0.48% 26
2018
Q4
$11M Hold
175,900
0.59% 25
2018
Q3
$13.6M Hold
175,900
0.55% 25
2018
Q2
$12.5M Hold
175,900
0.5% 25
2018
Q1
$13.3M Hold
175,900
0.57% 25
2017
Q4
$12.6M Hold
175,900
0.54% 27
2017
Q3
$14.3M Sell
175,900
-175,700
-50% -$13.4M 0.6% 24
2017
Q2
$24.9M Hold
351,600
1.16% 22
2017
Q1
$23.9M Buy
351,600
+33,200
+10% +$2.33M 1.13% 21
2016
Q4
$22.8M Hold
318,400
1.3% 21
2016
Q3
$25.2M Hold
318,400
1.46% 21
2016
Q2
$26.6M Buy
318,400
+15,500
+5% +$1.38M 2.01% 16
2016
Q1
$27.8M Hold
302,900
2.16% 13
2015
Q4
$30.6M Sell
302,900
-14,000
-4% -$1.46M 1.71% 17
2015
Q3
$31.1M Buy
316,900
+17,400
+6% +$1.93M 1.5% 14
2015
Q2
$35.1M Buy
299,500
+8,500
+3% +$929K 1.56% 15
2015
Q1
$28.6M Buy
291,000
+56,400
+24% +$5.73M 1.41% 16
2014
Q4
$22.1M Buy
234,600
+67,100
+40% +$6.94M 1.3% 19
2014
Q3
$17.8M Buy
167,500
+13,100
+8% +$1.28M 1.33% 17
2014
Q2
$12.8M Buy
154,400
+150,800
+4,189% +$11.7M 0.95% 27
2014
Q1
$255K Buy
+3,600
New +$282K 0.02% 39

Other funds holding GILD

Palo Alto Investors's GILD Position: Q1 2020 in Review

Palo Alto Investors sold out of Gilead Sciences (GILD) in Q1 2020, closing a stake of 39,300 shares — an estimated $2.55M sold.

Palo Alto Investors first reported a position in GILD in Q1 2014 and held it in 24 quarters. The position peaked at $35.1M in Q2 2015. 1,644 funds tracked by Wall St. Rank hold GILD as of Q1 2020.

  • Palo Alto Investors reported no remaining Gilead Sciences position as of Q1 2020 after selling out during the quarter.
  • Palo Alto Investors sold 39,300 Gilead Sciences shares in Q1 2020, an estimated $2.55M.
  • Palo Alto Investors first reported a position in Gilead Sciences in Q1 2014 and held it in 24 quarters.
  • Palo Alto Investors's Gilead Sciences position peaked at $35.1M in Q2 2015.
  • 1,644 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2020.

Based on Palo Alto Investors's 13F filing for Q1 2020, filed 15 May 2020.